Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Coleman

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
The British Journal of Cancer. Supplement|July 1, 1996
Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord culturesS T Palayoor, E A Bump, D M Saroff, et al.
Cancer Research|June 15, 1988
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazoleC N Coleman, R W Carlson, R A Artim, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1995
Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumoursB A Bornstein, T S Herman, J L Hansen, et al.
Science (New York, N.Y.)|May 20, 1988
Radioimmunotherapy with alpha-particle-emitting immunoconjugatesR M Macklis, B M Kinsey, A I Kassis, et al.
Blood|May 1, 1996
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcomeP M Mauch, L A Kalish, K C Marcus, et al.
Journal of the National Cancer Institute|December 19, 1990
Results of stereotactic brachytherapy used in the initial management of patients with glioblastomaJ S Loeffler, E Alexander, P Y Wen, et al.
The Cancer Journal From Scientific American|May 1, 1995
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular diseaseP M Mauch, L A Kalish, K C Marcus, et al.
Oncogene|October 26, 2005
Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cellsM-H Tsai, X Chen, G V R Chandramouli, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
The British Journal of Cancer. Supplement|July 1, 1996
Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord culturesS T Palayoor, E A Bump, D M Saroff, et al.
Cancer Research|June 15, 1988
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazoleC N Coleman, R W Carlson, R A Artim, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1995
Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumoursB A Bornstein, T S Herman, J L Hansen, et al.
Science (New York, N.Y.)|May 20, 1988
Radioimmunotherapy with alpha-particle-emitting immunoconjugatesR M Macklis, B M Kinsey, A I Kassis, et al.
Blood|May 1, 1996
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcomeP M Mauch, L A Kalish, K C Marcus, et al.
Journal of the National Cancer Institute|December 19, 1990
Results of stereotactic brachytherapy used in the initial management of patients with glioblastomaJ S Loeffler, E Alexander, P Y Wen, et al.
The Cancer Journal From Scientific American|May 1, 1995
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular diseaseP M Mauch, L A Kalish, K C Marcus, et al.
Oncogene|October 26, 2005
Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cellsM-H Tsai, X Chen, G V R Chandramouli, et al.
Pageof 14